Table 2.
Univariate and multivariate analysis of overall survival in 344 HCC patients
| Variables | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|
| Hazard Ratio | CI 95% | P | Hazard Ratio | CI 95% | P | |
| Age (≤60 / > 60) | 1.02 | 1–1.04 | 0.024* | 1.02 | 1–1.04 | 0.05 |
| Gender (M / F) | 1.43 | 0.9–2.26 | 0.129 | |||
| Grade (I + II / III + IV) | 1.16 | 0.92–1.46 | 0.218 | |||
| AJCC stage (I + II / III + IV) | 1.23 | 0.96–1.58 | 0.102 | |||
| COMMD1 (high / low) | 1.14 | 0.72–1.79 | 0.579 | |||
| COMMD2 (high / low) | 0.97 | 0.61–1.55 | 0.903 | |||
| COMMD3 (high / low) | 2.37 | 1.48–3.8 | 0.000* | 2.16 | 1.33–3.48 | 0.002* |
| COMMD4 (high / low) | 1.07 | 0.67–1.69 | 0.788 | |||
| COMMD5 (high / low) | 1.65 | 1.05–2.59 | 0.029* | 1.33 | 0.83–2.12 | 0.233 |
| COMMD6 (high / low) | 1.23 | 0.76–1.99 | 0.398 | |||
| COMMD7 (high / low) | 0.82 | 0.5–1.34 | 0.437 | |||
| COMMD8 (high / low) | 1.5 | 0.94–2.4 | 0.091 | |||
| COMMD9 (high / low) | 1.44 | 0.89–2.31 | 0.137 | |||
| COMMD10 (high / low) | 1.06 | 0.67–1.68 | 0.794 | |||
HCC Hepatocellular carcinoma, CI Confidence interval. * p < 0.05.